Pharmaceuticals, Biotechnology and Life Sciences
Common Stock Expected to Begin Trading on a Split-Adjusted Basis on December 2, 2025NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE)…
NEW HOPE, Pa., Nov. 26, 2025 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”),…
RADNOR, Pa., Nov. 26, 2025 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing…
$4.25 million upfront with up to an additional $4.1 million of potential aggregate gross proceeds upon the exercise in full…
— Lawsuit triggers 30-month stay under the Hatch Waxman Act — BRISBANE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) — Pacira…
COPENHAGEN, Denmark, November 26, 2025 – Bavarian Nordic A/S invites its shareholders for a meeting and dialogue with the company’s…
French operations to be concentrated at its Lyon site Final consolidation of R&D in Vienna Saint-Herblain (France), November 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced a…
NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf…
Live video webcast with Walter Klemp, Chairman and Chief Executive Officer, on Tuesday, December 2nd at 4:00 PM ET HOUSTON,…
HOUSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it…